Quick Links

Supported by City of Hope's NCI-funded Cancer Center Support Grant (CCSG)

 Hematologic Malignancies Program Publications, 2002

2006, 2005, 2004, 2003, 2002

Arber, D. A., Slovak, M. L., Popplewell, L., Bedell, V., Ikle, D., Rowley, J. D. "Therapy-related acute myeloid leukemia/myelodysplasia with balanced 21q22 translocations. "Am J Clin Pathol; 2002, 117(2): 306-13

Bhatia, R., Williams, A. D., Munthe, H. A. "Contact with fibronectin enhances preservation of normal but not chronic myelogenous leukemia primitive hematopoietic progenitors. "Exp Hematol; 2002, 30(4): 324-32

Chang, K. L., O'Donnell, M. R., Slovak, M. L., Dagis, A. C., Arber, D. A., Niland, J. C., Forman, S. J. "Primary myelodysplasia occurring in adults under 50 years old: a clinicopathologic study of 52 patients. "Leukemia; 2002, 16(4): 623-31.

Chang, Z., Westaway, S., Li, S., Zaia, J. A., Rossi, J. J., Scherer, L. J. "Enhanced expression and HIV-1 inhibition of chimeric tRNA(Lys3)- ribozymes under dual U6 snRNA and tRNA promoters. "Mol Ther; 2002, 6(4): 481-9.

Chu, P. G., Chen, Y. Y., Molina, A., Arber, D. A., Weiss, L. M. "Recurrent B-cell neoplasms after Rituximab therapy: an immunophenotypic and genotypic study. "Leuk Lymphoma; 2002, 43(12): 2335-41

Chu, P. G., Ishizawa, S., Wu, E., Weiss, L. M. "Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. "Am J Surg Pathol; 2002, 26(8): 978-88

Chu, P. G., Weiss, L. M. "Expression of cytokeratin 5/6 in epithelial neoplasms: an immunohistochemical study of 509 cases. "Mod Pathol; 2002, 15(1): 6-10

Chu, P. G., Weiss, L. M. "Keratin expression in human tissues and neoplasms. "Histopathology; 2002, 40(5): 403-39

Epel, M., Ellenhorn, J. D., Diamond, D. J., Reiter, Y. "A functional recombinant single-chain T cell receptor fragment capable of selectively targeting antigen-presenting cells. "Cancer Immunol Immunother; 2002, 51(10): 565-73

Fung, H. C., Nademanee, A. P. "Approach to Hodgkin's lymphoma in the new millennium. "Hematol Oncol; 2002, 20(1): 1-15.

Gallez-Hawkins, G., Lomeli, N. A., L. Li X, Yao, Z. Q., La Rosa, C., Diamond, D. J., Zaia, J. A. "Kinase-deficient CMVpp65 triggers a CMVpp65 specific T-cell immune response in HLA-A*0201.Kb transgenic mice after DNA immunization. "Scand J Immunol; 2002, 55(6): 592-8

Huang, Q., Chang, K. L., Gaal, K., Arber, D. A. "Primary effusion lymphoma with subsequent development of a small bowel mass in an HIV-seropositive patient: a case report and literature review. "Am J Surg Pathol; 2002, 26(10): 1363-7

Kashyap, A., Wingard, J., Cagnoni, P., Roy, J., Tarantolo, S., Hu, W., Blume, K., Niland, J., Palmer, J. M., Vaughan, W., Fernandez, H., Champlin, R., Forman, S., Andersson, B. S. "Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality. "Biol Blood Marrow Transplant; 2002, 8(9): 493-500

Kook, H., Risitano, A. M., Zeng, W., Wlodarski, M., Lottemann, C., Nakamura, R., Barrett, J., Young, N. S., Maciejewski, J. P. "Changes in T-cell receptor VB repertoire in aplastic anemia: effects of different immunosuppressive regimens. "Blood; 2002, 99(10): 3668-75.

Krishnan, A., Molina, A., Forman, S. J. "Organ transplantation in HIV-infected patients. "N Engl J Med; 2002, 347(22): 1801-3; author

Krishnan, A., Zaia, J., Molina, A. "Stem cell transplantation and gene therapy for HIV-related lymphomas. "J Hematother Stem Cell Res; 2002, 11(5): 765-75

La Rosa, C., Wang, Z., Brewer, J. C., Lacey, S. F., Villacres, M. C., Sharan, R., Krishnan, R., Crooks, M., Markel, S., Maas, R., Diamond, D. J. "Pre-clinical development of an Adjuvant-Free peptide vaccine with activity against CMV pp65 in HLA transgenic mice. "Blood; 2002, 100(10): 3681-9

Magnusson, M. K., Meade, K. E., Nakamura, R., Barrett, J., Dunbar, C. E. "Activity of STI571 in chronic myelomonocytic leukemia with a platelet- derived growth factor beta receptor fusion oncogene. "Blood; 2002, 100(3): 1088-91.

Melenhorst, J. J., Eniafe, R., Follmann, D., Nakamura, R., Kirby, M., Barrett, A. J. "Molecular and flow cytometric characterization of the CD4 and CD8 T- cell repertoire in patients with myelodysplastic syndrome. "Br J Haematol; 2002, 119(1): 97-105.

Michienzi, A., Li, S., Zaia, J. A., Rossi, J. J. "A nucleolar TAR decoy inhibitor of HIV-1 replication. "Proc Natl Acad Sci U S A; 2002, 99(22): 14047-52

Nakamura, R., Cortez, K., Solomon, S., Battiwalla, M., Gill, V. J., Hensel, N., Childs, R., Barrett, A. J. "High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation. "Bone Marrow Transplant; 2002, 30(4): 235-42.

Park, K. I., Ourednik, J., Ourednik, V., Taylor, R. M., Aboody, K. S., Auguste, K. I., Lachyankar, M. B., Redmond, D. E., Snyder, E. Y. "Global gene and cell replacement strategies via stem cells. "Gene Ther; 2002, 9(10): 613-24

Saunthararajah, Y., Nakamura, R., Nam, J. M., Robyn, J., Loberiza, F., Maciejewski, J. P., Simonis, T., Molldrem, J., Young, N. S., Barrett, A. J. "HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome. "Blood; 2002, 100(5): 1570-4.

Shih, C. C., DiGiusto, D., Mamelak, A., Lebon, T., Forman, S. J. "Hematopoietic potential of neural stem cells: plasticity versus heterogeneity. "Leuk Lymphoma; 2002, 43(12): 2263-8

Shilling, H. G., Guethlein, L. A., Cheng, N. W., Gardiner, C. M., Rodriguez, R., Tyan, D., Parham, P. "Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. "J Immunol; 2002, 168(5): 2307-15.

Somlo, G., Simpson, J. F., Frankel, P., Chow, W., Leong, L., Margolin, K., Morgan, R., Jr., Raschko, J., Shibata, S., Forman, S., Kogut, N., McNamara, M., Molina, A., Somlo, E., Doroshow, J. H. "Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer. "Br J Cancer; 2002, 87(3): 281-8

Strayer, D., Branco, F., Zern, M. A., Yam, P., Calarota, S. A., Nichols, C. N., Zaia, J. A., Rossi, J., Li, H., Parashar, B., Ghosh, S., Chowdhury, J. R. "Durability of transgene expression and vector integration: recombinant SV40-derived gene therapy vectors. "Mol Ther; 2002, 6(2): 227-37

Sun, J-Y., Krouse, R. S., Forman, S.F., Senitzer, D., Sniecinski, I., Chatterjee, S., Wong, K. K. "Immunogenicity of a P210BCR-ABL Fusion Domain Candidate DNA Vaccine Targeted to Dendritic Cells by an rAAV Vector In Vitro.. "Cancer Res; 2002; 62: 3175-3183

Sun, J. Y., Chatterjee, S., Wong, K. K., Jr. "Immunogenic issues concerning recombinant adeno-associated virus vectors for gene therapy. "Curr Gene Ther; 2002, 2(4): 485-500

Wang, J., Weiss, L. M., Chang, K. L., Slovak, M. L., Gaal, K., Forman, S. J., Arber, D. A. "Diagnostic utility of bilateral bone marrow examination: significance of morphologic and ancillary technique study in malignancy. "Cancer; 2002, 94(5): 1522-31.

Weisdorf, D. J., Anasetti, C., Antin, J. H., Kernan, N. A., Kollman, C., Snyder, D., Petersdorf, E., Nelson, G., McGlave, P. "Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation. "Blood; 2002, 99(6): 1971-7.

Yam, P. Y., Li, S., Wu, J., Hu, J., Zaia, J. A., Yee, J. K. "Design of HIV Vectors for Efficient Gene Delivery into Human Hematopoietic Cells. "Mol Ther; 2002, 5(4): 479-84.

Zaia, J. A. "Prevention of cytomegalovirus disease in hematopoietic stem cell transplantation. "Clin Infect Dis; 2002, 35(8): 999-1004

Zaia, J. A. "Prevention and management of CMV-related problems after hematopoietic stem cell transplantation. "Bone Marrow Transplant; 2002, 29(8): 633-8

Slovak, M. L., Zhang, F., Tcheurekdjian, L., Bobadilla, D., Bedell, V., Arber, D. A., Persons, D. L., Sosman, J. A., Murata-Collins, J. L. "Targeting multiple genetic aberrations in isolated tumor cells by spectral fluorescence in situ hybridization. "Cancer Detection & Prevention; 2002, 26(3): 171-9

List, A. F., Kopecky, K. J., Willman, C. L., Head, D. R., Slovak, M. L., Douer, D., Dakhil, S. R., Appelbaum, F. R. "Cyclosporine inhibition of P-glycoprotein in chronic myeloid leukemia blast phase. "Blood; 2002, 100(5): 1910-2

Wolman, S. R., Gundacker, H., Appelbaum, F. R., Slovak, M. L., Southwest Oncology, Group "Impact of trisomy 8 (+8) on clinical presentation, treatment response, and survival in acute myeloid leukemia: a Southwest Oncology Group study. "Blood; 2002, 100(1): 29-35

Slovak, M. L., Bedell, V., Popplewell, L., Arber, D. A., Schoch, C., Slater, R. "21q22 balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshop. "Genes, Chromosomes & Cancer; 2002, 33(4): 379-94

Sloand, E. M., Kim, S., Fuhrer, M., Risitano, A. M., Nakamura, R., Maciejewski, J. P., Barrett, A. J., Young, N. S. "Fas-mediated apoptosis is important in regulating cell replication and death in trisomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities. "Blood; 2002, 100(13): 4427-32

Molldrem, J. J., Leifer, E., Bahceci, E., Saunthararajah, Y., Rivera, M., Dunbar, C., Liu, J., Nakamura, R., Young, N. S., Barrett, A. J. "Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes.[summary for patients in Ann Intern Med. 2002 Aug 6;137(3):I-27; PMID: 12160383]. "Annals of Internal Medicine; 2002, 137(3): 156-63

Hensel, N., Melenhorst, J. J., Bradstock, K., Schwarer, A. P., Eniafe, R., Nakamura, R., Barrett, A. J. "Flow cytometric quantitation and characterization of the T-lymphocyte memory response to CMV in healthy donors. "Cytotherapy; 2002, 4(1): 29-40

Ito, J. I., Lyons, J. M. "Vaccination of corticosteroid Immunosuppressed mice against invasive pulmonary aspergillosis. "Journal of Infectious Diseases; 2002, 186(6): 869-871

Higuchi, M., Zeng, D., Shizuru, J., Gworek, J., Dejbakhsh-Jones, S., Taniguchi, M., Strober, S. "Immune tolerance to combined organ and bone marrow transplants after fractionated lymphoid irradiation involves regulatory NK T cells and clonal deletion. "Journal of Immunology; 2002, 169(10): 5564-70

Lacey, S. F., Gallez-Hawkins, G., Crooks, M., Martinez, J., Senitzer, D., Forman, S. J., Spielberger, R., Zaia, J. A., Diamond, D. J. "Characterization of cytotoxic function of CMV-pp65-specific CD8+ T-lymphocytes identified by HLA tetramers in recipients and donors of stem-cell transplants. "Transplantation; 2002, 74(5): 722-32

Holtz, M. S., Slovak, M. L., Zhang, F. Y., Sawyers, C. L., Forman, S. J., Bhatia, R. "Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation. "Blood; 2002, 99(10): 3792-3800

BenMohamed, L., Krishnan, R., Auge, C., Primus, J. F., Diamond, D. J. "Intranasal administration of a synthetic lipopeptide without adjuvant induces systemic immune responses. "Immunology; 2002, 106(1): 113-21

 Search

Go!
Advanced Search Options
News & Publications Search
NCI CCC LogoCity of Hope is one of 40 Comprehensive Cancer Centers, the highest designation bestowed by the National Cancer Institute and a recognition of excellence in cancer treatment, research, prevention and education.
City of Hope strongly supports and values the uniqueness of all individuals and promotes a work environment where diversity is embraced.
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HON code of the Healthcare on the Net Foundation.